La Frenaye, France

Mathieu Grandjean

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Les Laboratoires Servier. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mathieu Grandjean. Retrieved from https://idiyas.com/inventor/mathieu-grandjean-d4mcng8n

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mathieu Grandjean

Introduction

Mathieu Grandjean is a notable inventor based in La Frenaye, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on ivabradine.

Latest Patents

Grandjean holds a patent for a "Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid." This patent outlines a method for synthesizing ivabradine, which is crucial for its application in treating certain heart conditions.

Career Highlights

He is currently employed at Les Laboratoires Servier, a prominent pharmaceutical company known for its commitment to research and development. His work at Servier has allowed him to focus on advancing medical treatments and improving patient outcomes.

Collaborations

One of his notable collaborators is Alexandre Le Flohic, with whom he has worked closely on various projects related to pharmaceutical innovations.

Conclusion

Mathieu Grandjean's contributions to the field of pharmaceuticals, particularly through his patent on ivabradine, highlight his role as an influential inventor in the industry. His work continues to impact the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…